The regulator, which has faced criticism in the past over its failure to establish a policy, set out its position in a 12-page document.
The Securities and Exchange Commission has charged a trader with using fraudulent posts on Twitter to manipulate the stock price of Sarepta Therapeutics. James Alan Craig, the man at the center of the case, is alleged to have created a Twitter account that looked like it belonged to securities research firm Citron Research and used it to post lies about Sarepta.
Life sciences will be a keystone to the newly reconceptualized Google. Under the umbrella of the parent company Alphabet, life sciences will be the first standalone company to stand shoulder to shoulder with the search engine-focused Google.
A congressman is taking aim at perceived flaws in FDA's long-awaited, much-discussed guidance on the use of Twitter.
GlaxoSmithKline has shone in a ranking of the social media savvy of the 100 largest publicly traded firms in the United Kingdom. The Big Pharma ranked second on the list, an outcome that suggests at least some drugmakers compare favorably to their peers in other industries.
Large pharma companies are posting 530% more tweets a week than in 2013, a study by Ogilvy Healthworld found. The healthcare communications group tracked the social media activity of 14 large pharma companies for one week per month over three months.
Researchers at the University of Michigan are trying to speed toward their goal of enrolling 20,000 people in a study by piggybacking onto Facebook's vast social network. And the genotypic and phenotypic data gathering project is off to a brisk start, with more than 2,000 people signing up in the days after its public launch.
Harvard geneticist George Church has backed Open Humans, an online platform that asks people to openly share their genomes and other personal data. The idea is to marry the underlying principles of the open-source and quantified-self movements to make more data available to more researchers.
Having faced years of criticism for its failure to publish guidelines on how the industry can use social media, the FDA is now being chastised by the advocacy group Union of Concerned Scientists over its lack of a policy for its staff.
Who knew that China FDA's planned lifting of a ban on online drug sales meant the global pharmaceutical industry could become a subject of a Chinese version of palace intrigue?